Latest filing published 04 Jun 2026 for NervGen Pharma Corp., €2.0M.
Insider track record
No signal scores available.
Keith Vendola: trading record in brief
This profile gathers the share dealings of Keith Vendola in NervGen Pharma Corp. We count 2 filings, every one of them for a trade on 27 April 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 4 June 2026 with an option exercise (€2.0M) in NervGen Pharma Corp. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Keith Vendola
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 812,002 shares@ CA$3.92100.0% of flowOptionsTSXSEDI:4729336
- OptionsTSXSEDI:4729329
2 of 2 declarations